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Abstract Comprehensive information on neurodevelop-
mental outcome in children and adolescents with chronic
kidney disease is still limited. Intellectual performance (IP)
and motor performance (MP) were systematically assessed
in 27 patients at a median age of 14.1 years (range 6.5–17)
and 6 years (range 0.5–12.7) after renal transplantation
(RTPL). IP was analyzed with the Wechsler Intelligence
Scale for Children-III (WISC-III) in 25 patients and by the
Kaufman Assessment Battery for Children in two patients.
MP was evaluated by the Zurich Neuromotor Assessment.
Median full- scale intelligent quotient (FSIQ) was 97 (range
49–133). Twenty-one patients had an FSIQ ≥ 85 (i.e. ≥
mean–1 standard deviation). The five patients with neuro-
logical comorbidity had a median FSIQ of 81 (range 49–
101). Verbal IQ (VIQ) (median 104; range 50–146) was
significantly (p<0.01) higher than performance IQ (PIQ)
(median 88; range 48–117). The PIQ was significantly
lower compared with controls (p<0.007), and patients
scored significantly lower compared with controls in five
of 11 subtests of the Wechsler Scale. All MP tasks were
significantly (p<0.01) lower than in controls, and also in
children without neurological comorbidity. Socioeconomic
status was significantly correlated with FSIQ (p=0.03). IP
after RTPL was within the normal range for the majority of
children. PIQ was lower compared with VIQ, and MP was
significantly affected in all children after RTPL.
Keywords Renal transplantation . Outcome . Intellectual
performance .Motor performance . Neurodevelopmental
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Introduction
Comprehensive data on neurodevelopmental outcome, i.e.
intellectual performance (IP) and motor performance (MP),
in children with chronic kidney disease [1–6] and in
particular after renal transplantation (RTPL) [2, 7–10] are
still limited. Published studies have focussed either on IP
[1–5, 7] or on MP [6, 8]. and only a few studies have
assessed both [9, 10].
The majority of the children on dialysis had IP scores in
the lower normal range [1, 2]. Increased disease severity,
longer disease duration, and younger age at onset of kidney
disease potentially placed children with chronic kidney
disease at increased risk of neurocognitive deficits [5].
Further associations of impaired IP were younger age at the
start of renal replacement therapy and longer duration of
dialysis [1, 5]. Children showed improvement in specific
aspects of IP after RTPL (e.g. mental processing speed and
sustained attention) compared with those on dialysis [4, 7,
10]. In infants transplanted before the age of 30 months,
comparison of individual cognitive and motor function
revealed an improvement in both areas after RTPL [10].
However, mainly global measures of intelligence were
used, and subdimensions of intelligence such as verbal
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intelligence quotient (VIQ) and performance IQ (PIQ) were
not systematically analyzed [5, 9].
Assessment of neuromotor function only included
technical examinations, such as electroencephalograms,
computed tomographic scan, magnetic resonance imaging,
and nerve conduction velocity, indicating neurological
deficits in up to 20% of transplanted children [9]. To date,
no study has assessed MP in school-aged children using a
standardized motor assessment battery. A preliminary study
from our unit had shown that MP was significantly
impaired in children starting renal replacement therapy
before 5 years of age [11].
Some studies were based on a small number of patients
[1, 7] or focused only on special risk groups by including
children suffering from chronic kidney disease at a young
age (3 months to 5 years) [1, 3, 9, 10]. Other authors [3, 9]
demonstrated that children may manifest a variety of major
or minor neurological complications ranging from cerebro-
vascular events to reduced head circumference size. It is
thus conceivable that motor impairment may be found in
children after RTPL also in the absence of major neurolog-
ical events, reflecting milder neurological injury. Addition-
ally, we and others [12] have shown that IP and MP may be
related in children at risk for neurodevelopmental impair-
ments, such as prematurely born children. We thus aimed to
determine this relationship in children after RTPL.
The aim of this study was to assess IP and MP in
children and adolescents after RTPL using standardized and
validated methods. Additionally, medical, socioeconomic,
and family-related predictors (e.g. marital status, mother
tongue, number of siblings) of IP and MP were evaluated.
Methods
Patients
Forty patients underwent RTPL at our hospital between
1995 and 2005. Inclusion criteria were RTPL, age > 5 years
at examination, and follow-up at our unit. Neurodevelop-
mental outcome was evaluated in 27 (15 boys, 12 girls) out
of 38 eligible patients (Fig. 1). The underlying diseases
were acquired, congenital, or inherited in six, eight, and 13
patients, respectively. Five patients had neurological
comorbidity: neonatal hypoxia (1), cerebral infarct (1),
severe deafness (1), severe visual impairment (1), and
Joubert syndrome (1). Three patients were born premature-
ly. Thirteen patients did not participate: two had died with
good graft function and one had severe neurological deficit
(neonatal cerebral infarct) and could not be adequately
examined, and parents did not provide consent for ten
patients. Two of these children were born prematurely;
none had a neurological comorbidity.
Immunosuppression at examination consisted of cyclo-
sporine A (17; trough level 80–120 ng/ml) or tacrolimus
(10; trough level 4–8 ng/ml), mycophenolate mofetile (19;
dose 1,200 and 900 mg/m2 body surface in patients on
cyclosporine A and tacrolimus, respectively) or azathio-
prine (7; dose 1 mg/kg body weight), and low-dose
alternate-day prednisone (range 2.5–5.0 mg per dose; 21).
Six patients were off steroids.
Renal function was assessed as estimated glomerular
filtration rate (GFR: ml/min per 1.73 m2 body surface area)
calculated by the Schwartz formula with a k-factor of 40
based on local comparison with Cr-EDTA clearance
measurements [13]. Casual blood pressure was measured
in the sitting position. Indication for antihypertensive
treatment was a systolic blood pressure >95th percentile
[14]. At the time of evaluation, systolic blood pressure of
all patients was <95th percentile. Height, weight, and body
mass index (BMI: kg/m2) were correlated to normative
Swiss data [15].
Assessment of intellectual performance (IP) and motor
performance (MP)
The examination of IP and MP took a full morning (09.00–
13.00). The order of examination was: Joining phase, IP
testing, break, MP testing, and neurological examination.
Wechsler Intelligence Scale for Children-III (WISC-III)
The Wechsler Intelligence Scale for Children-III (WISC-III)
is used in children aged 6–16 years (school age) and is
organized into three IQ scores: full-scale IQ (FSIQ), VIQ,
and PIQ, with a mean score of 100 and a standard deviation
WISC – III: Wechsler Intelligence Scale for Children-III 
K – ABC: Kaufman Assessment Battery for Children 
Zurich NMA: Zurich Neuromotor Assessment 
38 patients 
Motor performance Intellectual performance 
WISC – III: n = 25 
K – ABC: n = 2 
Zurich NMA: n = 26 
 
10: no consent 
1: testing not 
possible 
Part I 
10: no consent 
2: testing not 
possible 
Fig. 1 Algorithm of all 38 surviving patients transplanted between
1995 and 2005. Included in Part I: 27. Age at transplantation: 2–
15 years; age at evaluation: 6–17 years
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(SD) of 15. In this study, children were examined with the
WISC-III [16, 17]. The WISC-III consists of VIQ and PIQ,
which form the FSIQ. The VIQ is composed of subtest
information, comprehension, arithmetic, similarities, and
vocabulary; the PIQ consists of the subtests coding, picture
completion, picture arrangement, block design, and object
assembly. The subtest digit span is a separate subtest, which
is not included in the verbal subtest. The VIQ and PIQ are
combined into the FSIQ. In Switzerland, normal age at
entry in primary school is 6–7 years, and an FSIQ>85, i.e.
≥ mean–1 SD, is mandatory to attend normal school.
Kaufman Assessment Battery for Children (Kaufman-ABC)
The Kaufman Assessment Battery for Children (K-ABC) is
used in preschool children and is composed of two parts:
the mental processing composite and the achievement scale
[18, 19].
Zurich Neuromotor Assessment (Zurich NMA)
The Zurich Neuromotor Assessment (NMA) is a standard-
ized and reproducible testing procedure assessing timed
performance and associated movement quality of a variety
of motor tasks. Age- and gender-specific normative data are
based on 662 healthy children and adolescents recruited
from the local Zurich and aged between 5 and 18 years [20,
21]. The testing procedure includes assessment of pure
motor tasks, adaptive fine-motor tasks, adaptive gross-
motor tasks, static balance, and stress gaits [20, 21]:
Repetitive, alternating, and sequential movements were
assessed by the performance of finger, hand, and foot
movements, alternating hand pronation–supination and foot
movements, and sequential finger movements. Pegboard
examination was conducted according to age. Dynamic
balance was analyzed by an elastic cord fixed 20 cm above
the floor between two metal poles placed 4 m apart. The
exercise consisted of two tasks: the first was side-to-side
jumping keeping the feet together; the second was forward
jumping. Static balance was assessed by asking the child to
choose one leg and stand on it for as long as possible, time
limit 60 s. For this analysis, only time performance was
used. The child’s performance is videotaped and timed with
a watch. The results of the Zurich NMA are expressed as
four motor components: (1) the pure motor component
combines the timed performance of all repetitive, alternat-
ing, and sequential movements of both extremities; (2) the
adaptive fine-motor component combines all timed per-
formances of the peg board; (3) the adaptive gross-motor
component combines the results of the dynamic balances;
and (4) the static balance. Intraobserver reliability for timed
performance of the components pure motor, adaptive fine
motor, gross motor, and static balance is 0.95, 0.99, 0.99,
and 0.99, respectively [20, 21]. The intraobserver reliability
is derived from the normative sample. All Zurich NMA
tasks are expressed as standard deviation score (SDS or Z
score) derived from the age- and gender-related reference
population.
Socioeconomic status (SES)
Socioeconomic status (SES) can be defined by a variety
of factors. We used paternal employment and maternal
education for defining SES. SES was defined and
validated for Swiss children and is expressed by the
sum of a six-point scale of paternal occupation and
maternal education [22]. The method has already been
used in other studies assessing the influence of SES on
intellectual outcome [12].
Procedure
The study was approved by the Ethical Committee of the
University Hospital of Zurich, and written informed
consent was obtained from all parents and patients older
than 10 years. All 27 patients were tested by one
pediatrician, who was not involved in the patient care and
was unaware of the current graft function. The examiner
was supervised by video recordings.
Statistical analysis
The analyses were performed using the SPSS statistical
software package (Version 11.5, SPSS Inc, Chicago, IL,
USA). Data are presented as mean (± SD) or median
(range) if data were not normally distributed. The null
hypothesis tested against was that children with RTPL had
no impairment of IP and MP in comparison with healthy
children. Differences between groups were analyzed using
Student’s t test or Mann–Whitney U test, depending on data
distribution. To evaluate associations of IP and MP, Spear-
man’s rank correlation coefficients were computed. Uni-
variate analysis was followed by multiple regression
analysis to determine the independent association between
PIQ and MP. Proportions between the groups were
compared by Fisher’s exact test. A p value of < 0.05 was
considered significant.
Results
Clinical evaluation
Twenty-seven patients were examined at an age of
14.1 years (range 6.5–17) and 6 years (range 0.5–12.7)
after RTPL (Tables 1 and 2). Estimated glomerular filtration
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rate was 81 ml/min per 1.73 m2 (range 32–115), and 14
patients were on antihypertensive medication.
School performance
Median age at school entry was 7.3 years (6.3–7.8) and was
comparable in patients with and without neurological
comorbidity. Two children attended the nursery at the time
of evaluation. Nine of 25 children had repeated a school
grade, and three attended a special first class taking 2 years
instead of 1 year. Four of five children with neurological
comorbidity went to a special school, whereas all school-
aged children without neurological comorbidity (n=20)
attended normal school (Fisher’s exact test, p=0.0007).
Intellectual performance (IP)
WISC-III was examined in 25 patients (Tables 2 and 3):
Median FSIQ in all tested children was 97 (49–133), with
Table 1 Clinical data of 27 patients
Parameter Median (range)
or number of patients
Gender (male/female) 15/12
Age (years) at investigation 14.1 (6.5–17)
Age (years) at RTPL 9.2 (2–15)
Living related RTPL/deceased donor 17/10
Follow-up time since RTPL (years) 6 (0.5–12.7)
Glomerular filtration rate
(ml/min per 1.73 m2)
81 (32–115)
Height SDS –0.9 (−2.9 to 0.8)
BMI SDS 0.16 (−1.4 to 1.9)
Age (years) at onset of dialysis (n=19) 7.7 (0.25–15)
Haemodialysis/peritoneal dialysis before
RTPL
8/11
Duration (years) of dialysis (n=19) 1.4 (0.2–4.6)
With/without neurological comorbidity 5/22
RTPL renal transplantation, SDS standard deviation score, BMI body
mass index
Table 2 Diagnosis, intellectual performance, and risk factors of all 27 patients
Patient Diagnosis Full scale IQ Verbal IQ Performance IQ Risk factors
1 Renal dysplasia 81 86 80 –
2 Renal dysplasia and PUV 95 108 84 –
3 Renal dysplasia 109 110 104 –
4 Denys-Drash-syndrome 112 110 112 –
5 Neonatal shock kidneys 76 78 75 Neonatal asphyxia
6 ARPKD 102 118 85 –
7 Atypical HUS 85 88 85 –
8 Bone marrow transplantation associated
renal failure
81 89 76 Cerebral infarct
9 Renal dysplasia and PUV 132 140 117 Premature birth
(36 week)
10 Renal-hepatic-pancreatic dysplasia 88 K-ABC K-ABC –
11 FSGS 101 118 84 Premature birth
(36 week)
12 DMS 101 K-ABC K-ABC Severe visual impairment
13 FSGS 103 117 88 –
14 Cystinosis 100 104 97 –
15 IgA-nephropathy 106 117 92 Premature birth
(34 week)
16 Joubert syndrome 49 50 48 Joubert syndrome
17 Cystinosis 71 76 68 –
18 Branchio-oto-renal syndrome 85 85 89 Severe deafness
19 Renal dysplasia and PUV 90 95 88 –
20 Denys-Drash-syndrome 133 146 109 –
21 Renal dysplasia 97 109 85 –
22 Cystinosis 99 104 95 –
23 FSGS 87 89 88 –
24 Nephronophthisis 109 113 101 –
25 Renal dysplasia and PUV 88 97 81 –
26 FSGS 114 117 107 –
27 1o Hyperoxaluria 75 82 69 –
IgA Immunoglobulin A, PUV posterior urethral valves, ARPKD autosomal recessive polycystic kidney disease, HUS hemolytic uremic syndrome,
FSGS focal segmental glomerulosclerosis, DMS diffuse mesangial sclerosis, K-ABC Kaufman Assessment Battery for Children
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VIQ and PIQ of 104 (50–146) and 88 (48–117), respec-
tively. Nineteen, two, and six children had an FSIQ
between 85 and 115 (i.e. mean ± 1 SD), > 115 and < 85,
respectively. The five patients with neurological comorbid-
ity had a median FSIQ of 81 (range 49–101).
VIQ was significantly (p<0.01) higher than PIQ. The
PIQ was significantly (p<0.007) lower compared with
controls. The patients also scored significantly lower
compared with controls in five of the 11 subtests, i.e.
similarities, digit span, coding, picture completion, and
object assembly (p<0.05). The scoring was also signifi-
cantly lower (p<0.05) when patients with neurological
comorbidity were excluded. Two preschool children with-
out neurological comorbidity were assessed with the K-
ABC, resulting in an FSIQ of 88 and 101, respectively.
Motor performance (MP)
MP could be assessed in 26 of 28 eligible patients. Two
patients with severe neurological comorbidity (Joubert syn-
drome and severe cerebral infarct) could not be formally
tested. Significant impairment compared with healthy chil-
dren was observed in all four motor components (Fig. 2). The
proportion of children with impaired MP, defined as values
< 10th percentile, ranged from 32% to 60%. The five patients
with neurological comorbidity had significantly lower scores
in all tasks compared with 21 patients without comorbidity
(p<0.01). MP was also poorer in children without neuro-
logical comorbidity compared with controls (one-sample t
test: pure motor task p<0.001, adaptive fine motor p=0.01,
adaptive gross motor p<0.001, static balance p=0.001).
Table 3 Intellectual performance (only Wechsler Intelligence Scale for Children-III): data given for all 25 children and 20 children without
neurological comorbidity
IQ subscales (n=25) P value* IQ subscales (n=20) P value*
Full-scale IQ 97 (49–133) 0.173 100 (71–133) 0.760
Verbal-scale IQ 104 (50–146) 0.663 109 (76–146) 0.089
Information 10 (1–19) 0.283 10 (4–19) 0.953
Comprehension 10 (3–19) 0.492 11 (5–19) 0.153
Arithmetic 9 (1–15) 0.521 10 (5–15) 0.484
Similarities 12 (2–18) 0.028 13 (3–18) 0.015
Vocabulary 11 (1–19) 0.796 12 (4–19) 0.121
Digit span 8 (1–13) 0.001 8 (1–13) 0.003
Performance-scale IQ 88 (48–117) 0.001 88 (68–117) 0.007
Coding 8 (1–15) 0.015 8 (4–15) 0.049
Picture Completion 8 (2–13) 0.001 8 (2–13) 0.001
Picture arrangement 9 (1–17) 0.207 10 (1–17) 0.807
Block design 9 (1–17) 0.178 9 (1–17) 0.576
Object assembly 6 (1–12) 0.001 6 (2–12) 0.001
IQ intelligence quotient
* Univariate t test compared with normative data [17]
-6
-5
-4
-3
-2
-1
0
1
S
D
S
*Number of patients (%) below 10
th
 percentile.  
           p<0.001; *12 (55)     p=0.001; * 7 (32)   p<0.001; *13 (59)     p=0.001;* 7 (32) 
Pure motor 
task 
Adaptive gross 
motor task 
Adaptive fine 
motor task 
Static 
balance 
Fig. 2 Motor performance [Zur-
ich Neuromotor Assessment
(Zuric NMA)] of 26 patients
after renal transplantation: data
given as standard deviation
score (SDS): mean and 95%
confidence interval
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Socioeconomic status (SES)
Mean SES in this sample was 7.3 (range 3–12).
Associations of intellectual performance (IP) and motor
performance (MP)
Patients without neurological comorbidity or further risk
factors for development (e.g. premature birth, cerebral
infarct, neonatal asphyxia, visual impairment, and deafness)
had higher scores for IP and MP compared with patients
with comorbidity or risk factors. Neurological comorbidity
was negatively associated with FSIQ (Mann-Whitney U test
p=0.03). There was a significant association between PIQ
and pure-motor (Spearman: r=0.45; p=0.03) and adaptive
fine-motor (Spearman: r=0.50; p=0.01) tasks. After adjust-
ing for neurological comorbidity, the association between
PIQ and MP (both pure and adaptive fine motor) was no
longer statistically significant. SES was significantly asso-
ciated with FSIQ (Spearman: r=0.41; p=0.03), but not with
MP. Patient-, family-, and illness-related variables, e.g.
glomerular filtration rate, prednisone therapy, age at onset
and duration of dialysis, and age at RTPL, were not
significantly associated with IP and MP. There was also
no gender-related difference in MP or IP.
Discussion
Long-term outcome after RTPL in children, i.e. patient and
graft survival, has steadily improved over the last decades
[23, 24]. However, information on comprehensive and
detailed neurodevelopmental outcome after RTPL is still
limited [1–9]. This cross-sectional study presents detailed
measures of IP and MP in children after RTPL.
The majority of our patients scored an FSIQ within the
lower normal range. This observation is consistent with
other studies [1, 2, 4, 5, 7, 9]. Studies analyzing only IP
differed significantly in their design [1–5, 7]. Focusing on
15 infants initiating long-term peritoneal dialysis in the first
year of life, median FSIQ was in the lower normal range
(91, range 50–102), and only one patient had an FSIQ
above mean (> 100) [1]. Similar results were obtained by
Warady et al. who evaluated 28 children undergoing
peritoneal dialysis at the very young age of ≤ 3 months.
General mental development scores were in the average
range (defined as 85–115) in 79% of the children tested
> 4 years of age [3].
PIQ was significantly lower than VIQ in our patients.
These findings are in line with previous studies [6, 8].
Although not statistically significant, PIQ after RTPL was
associated with MP as assessed by the Zurich NMA.
However, the primary reasons for impaired MP in
children suffering from chronic kidney disease remain
unclear.
In our series, IP was not correlated with illness-related
variables, e.g. age at onset of dialysis, duration of dialysis, age
at RTPL, graft function, and prednisone therapy. These results
are at variance with reports showing that disease severity,
longer disease duration, and younger age at onset of kidney
disease were significant clinical predictors of IP [2, 5]. In
particular, children with increased disease severity and a low
glomerular function were potentially placed at increased risk
of neurocognitive deficits [5]. Explanations for the absent
impact of illness-related variables include the rather homo-
geneous population, with the majority of children having a
good graft function and the fact that neurodevelopmental
evaluation was performed 6 years after RTPL. A long
interval since RTPL may efface a correlation between
pretransplantation factors and IP and MP. However, the fact,
that this analysis only included patients after RTPL implies
caution by extrapolating conclusions and represents an
acknowledged limitation of our data. Consistent with other
reports, SES was significantly correlated with IP [22].
This study reports the first comprehensive analysis of MP
after RTPL using a standardized and validated method
(Zurich NMA). Motor performance was significantly im-
paired in the transplanted children and adolescents—also in
patients without neurological comorbidity—with 32–59% of
patients scoring < 10th percentile in all components.
Specifically, the pure motor task and the adaptive gross-
motor component were mostly affected. Impairment of the
pure-motor task and the adaptive gross-motor taskmay lead to
clumsiness in school-aged children and therefore substantially
negatively affect their academic performance and competence
in other developmental areas, such as communication and
social interaction with peers, and thus profoundly influence
feelings of well-being and self-esteem.
General muscular hypotonia has also been observed in
nine, four, and two children with chronic kidney disease, on
dialysis, and after RTPL, respectively [6]. Motor perfor-
mance assessed by the Bayley Scales of Infant Develop-
ment was normal in 76% of children transplanted at an age
< 5 years, and similar to our own findings, neurological
comorbidity was the most negative predictor [9].
Patient- and illness-related variables, e.g. glomerular
filtration rate, prednisone therapy, age at onset and duration
of dialysis, and age at RTPL, had no significant association
concerning IP and MP in our patients, whereas SES was the
only predictor of IP. Neurological comorbidity was the
most significant correlating factor negatively influencing
both IP and MP. There are a variety of reasons for
neurological comorbidities in patients with chronic renal
diseases, e.g. cerebral infarct, neonatal asphyxia, syndromic
maldevelopment of the brain, visual impairment, and
deafness.
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Few studies have assessed patients longitudinally before
and after RTPL [4, 7, 10]. One study reported an
improvement of cognitive and psychomotor function after
RTPL [10], whereas there was no difference in FSIQ. A
further study showed that transplanted patients did signif-
icantly better in achievement tests of written language and
in school performance [4]. Mental processing speed and
sustained attention improved in nine children after RTPL
[7]. Taken together, the majority of these longitudinal
observations suggest that successful RTPL has a significant
impact on neurodevelopment performance.
Our cross-sectional study of neurodevelopmental outcome
in children after RTPL confirmed our hypothesis. It indicates a
normal intellectual functioning for the majority of patients in
the majority of subtests but a significantly impaired MP.
Neurological comorbidity is associated with MP and IP. The
lower PIQ might be related to impaired MP. A detailed
neurodevelopmental and motor assessment of children with
chronic kidney disease provides both the possibility of
defining their specific requirements and of developing
promotional programs individually focussed on these children.
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